Publications
2025
The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post-hoc analysis of GLORIA-AF registry.
Huang, B., Liu, Y., Lam, H. M., Ishiguchi, H., Chao, T. -F., Huisman, M. V., . . . GLORIA‐AF Investigators. (2025). The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post-hoc analysis of GLORIA-AF registry.. European journal of clinical investigation, e14378. doi:10.1111/eci.14378
2024
Cardiovascular Benefits and Safety Profile of Macrolide Maintenance Therapy in Patients with Bronchiectasis.
Guo, R., Wat, D., Lam, S. H. M., Bucci, T., Tsang, C. T. -W., Cai, A. -P., . . . Yiu, K. -H. (2024). Cardiovascular Benefits and Safety Profile of Macrolide Maintenance Therapy in Patients with Bronchiectasis.. The European respiratory journal, 2401574. doi:10.1183/13993003.01574-2024
Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: A report from the GLORIA-AF registry phase II/III.
Liu, Y., Chen, Y., Olier, I., Ortega-Martorell, S., Huang, B., Ishiguchi, H., . . . GLORIA‐AF Investigators. (n.d.). Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: A report from the GLORIA-AF registry phase II/III.. European Journal of Clinical Investigation. doi:10.1111/eci.14371
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.
Liu, Y., Chen, Y., Lam, S. H. M., Huang, B., Romiti, G. F., Alam, U., . . . GLORIA‐AF Investigators. (2024). Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.. Diabetes, obesity & metabolism, 26(12), 5795-5804. doi:10.1111/dom.15950
Long-term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the GLORIA-AF registry.
Li, M., Huang, B., Lam, S. H. M., Ishiguchi, H., Liu, Y., Olshansky, B., . . . Lip, G. Y. H. (2024). Long-term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the GLORIA-AF registry.. European journal of clinical investigation, e14347. doi:10.1111/eci.14347
Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry
Huang, B. I., Li, M., Liu, Y., Lam, H. M., Ishiguchi, H., Chao, T. F., . . . Lip, G. (2024). Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry. European Heart Journal, 45(Supplement_1). doi:10.1093/eurheartj/ehae666.3154
Stratification of residual thromboembolic risk among anticoagulated atrial fibrillation patients: a hierarchical cluster analysis from a global, real-world population
Ishiguchi, H., Abdul-Rahim, A. H., Huang, B., Lam, H. M., Liu, Y., Olshansky, B., . . . Lip, G. Y. H. (2024). Stratification of residual thromboembolic risk among anticoagulated atrial fibrillation patients: a hierarchical cluster analysis from a global, real-world population. European Heart Journal, 45(Supplement_1). doi:10.1093/eurheartj/ehae666.480
Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry
Huang, B., Lam, H. M., Ishiguchi, H., Liu, Y., Chao, T. F., Olshansky, B., . . . Lip, G. (2024). Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry. European Heart Journal, 45(Supplement_1). doi:10.1093/eurheartj/ehae666.3319
Worldwide Stroke Burden Due to Low Physical Activity and High Body Mass in Older People: Insights From the Global Burden of Disease 2019
Worldwide Stroke Burden Due to Low Physical Activity and High Body Mass in Older People: Insights From the Global Burden of Disease 2019 (2024). doi:10.1161/blog.20241028.912793
Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.
Ishiguchi, H., Abdul-Rahim, A. H., Huang, B., Lam, S. H. M., Liu, Y., Olshansky, B., . . . GLORIA-AF Investigators. (2024). Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.. Journal of general internal medicine. doi:10.1007/s11606-024-09045-6
Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.
Janota, O., Mantovani, M., Kwiendacz, H., Irlik, K., Bucci, T., Lam, S. H. M., . . . Nabrdalik, K. (2024). Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.. Cardiovascular diabetology, 23(1), 326. doi:10.1186/s12933-024-02420-x
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.
Lam, S. H. M., Romiti, G. F., Olshansky, B., Chao, T. -F., Huisman, M. V., & Lip, G. Y. H. (2024). Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.. Internal and emergency medicine. doi:10.1007/s11739-024-03629-0
Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study.
Shi, L. -H., Lam, S. H. M., So, H., Meng, H., & Tam, L. -S. (2024). Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study.. Seminars in arthritis and rheumatism, 67, 152477. doi:10.1016/j.semarthrit.2024.152477
Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.
Lam, S. H. M., Alam, U., & Lip, G. Y. H. (2024). Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.. The American journal of cardiology, 223, 183-185. doi:10.1016/j.amjcard.2024.05.001
Refining the Cardiovascular Health Score in Patients With Type 2 Diabetes: Challenges and Opportunities.
Lam, S. H. M., Alam, U., & Lip, G. Y. H. (2024). Refining the Cardiovascular Health Score in Patients With Type 2 Diabetes: Challenges and Opportunities.. JACC. Asia, 4(6), 465-467. doi:10.1016/j.jacasi.2024.04.004
Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
Meng, H., Lam, S. H., So, H., & Tam, L. -S. (2024). Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.. Seminars in arthritis and rheumatism, 65, 152416. doi:10.1016/j.semarthrit.2024.152416
2023
Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study.
Shi, L. -H., Lam, S. H., So, H., Chan, C. Y., Li, T. K., Szeto, C. -C., & Tam, L. -S. (2023). Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study.. Clinical and experimental hypertension (New York, N.Y. : 1993), 45(1), 2205056. doi:10.1080/10641963.2023.2205056
Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.
So, H., Lam, T. O., Meng, H., Lam, S. H. M., & Tam, L. -S. (2023). Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.. Annals of the rheumatic diseases, 82(11), 1387-1393. doi:10.1136/ard-2023-224185
Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.
Lam, T. O., Cheng, I. T., Lam, S. H., Lam, S. H., Mok, C. C., Ho, C. T., . . . Tam, L. -S. (2023). Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.. Rheumatology (Oxford, England), 62(9), 2998-3005. doi:10.1093/rheumatology/kead039
2022
High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study.
Shi, L. -H., Lam, S. H., So, H., Li, E. K., Li, T. K., Szeto, C. -C., & Tam, L. -S. (2022). High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study.. Therapeutic advances in musculoskeletal disease, 14, 1759720X221122401. doi:10.1177/1759720x221122401
2021
The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.
Wu, D., Wong, P., Lam, S. H. M., Li, E. K., Qin, L., Tam, L. -S., & Gu, J. (2021). The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.. Rheumatology (Oxford, England), 60(4), 1963-1973. doi:10.1093/rheumatology/keaa629
Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis.
Lam, S. H., So, H., So, H., Cheng, I. T., Li, E. K., Wong, P., . . . Tam, L. -S. (2021). Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis.. Therapeutic advances in musculoskeletal disease, 13, 1759720X211027712. doi:10.1177/1759720x211027712
2020
DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.
Lam, S. H. M., Cheng, I. T., Li, E. K., Wong, P., Lee, J., Yip, R. M. -L., . . . Tam, L. -S. (2020). DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.. Annals of the rheumatic diseases, 79(10), 1320-1326. doi:10.1136/annrheumdis-2020-217595
2019
Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.
Wu, D., Griffith, J. F., Lam, S. H. M., Wong, P. C. H., Shi, L., Li, E. K., . . . Tam, L. -S. (2019). Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.. Arthritis research & therapy, 21(1), 265. doi:10.1186/s13075-019-2043-3
2018
Dr. Tam, <i>et al,</i> reply.
Lam, S. H. -M., Shen, J., & Tam, L. -S. (2018). Dr. Tam, <i>et al,</i> reply.. The Journal of rheumatology, 45(9), 1330-1332. doi:10.3899/jrheum.180439
Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.
Shen, J., Lam, S. H., Shang, Q., Wong, C. -K., Li, E. K., Wong, P., . . . Tam, L. -S. (2018). Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.. The Journal of rheumatology, 45(2), 218-226. doi:10.3899/jrheum.170025